Fate Therapeutics Reports New Employee Inducement Award Under Nasdaq Listing Rule 5635(c)(4)

Go back to Fate Therapeutics Reports New Employee Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
FATE THERAPEUTICS (NASDAQ: FATE) Delayed: 2.06 +0.09 (4.57%)
Previous Close $1.97    52 Week High $4.76 
Open $2.00    52 Week Low $1.46 
Day High $2.16    P/E N/A 
Day Low $1.93    EPS $-1.91 
Volume 4,698,730